Cargando…
Targeting PYCR2 inhibits intraperitoneal metastatic tumors of mouse colorectal cancer in a proline‐independent approach
Whether proline deficiency is a metabolic vulnerability in colorectal tumors is unknown. The aim of this study was to investigate the effects of proline metabolism‐related genes and exogenous proline on the progression of colorectal cancer (CRC). We aimed to further clarify the role of pyrroline‐5‐c...
Autores principales: | Zhang, Qi, Luo, Hai, Xun, Jing, Ma, Yuan, Yang, Lei, Zhang, Lanqiu, Wang, Ximo, Yu, Xiangyang, Wang, Botao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9986086/ https://www.ncbi.nlm.nih.gov/pubmed/36308281 http://dx.doi.org/10.1111/cas.15635 |
Ejemplares similares
-
In crystallo screening for proline analog inhibitors of the proline cycle enzyme PYCR1
por: Christensen, Emily M., et al.
Publicado: (2021) -
SIRT3 regulates cancer cell proliferation through deacetylation of PYCR1 in proline metabolism()
por: Chen, Shuaiyi, et al.
Publicado: (2019) -
Hydroxytyrosol Inhibits MDSCs and Promotes M1 Macrophages in Mice With Orthotopic Pancreatic Tumor
por: Wang, Botao, et al.
Publicado: (2021) -
miR-3065-3p promotes stemness and metastasis by targeting CRLF1 in colorectal cancer
por: Li, Yifan, et al.
Publicado: (2021) -
Cancer-associated fibroblasts require proline synthesis by PYCR1 for the deposition of pro-tumorigenic extracellular matrix
por: Kay, Emily J., et al.
Publicado: (2022)